#USA #Woburn #Ellacor #Cytrellis #Micro-Coring

Cytrellis' ellacor® Earns 2026 NewBeauty Award

In a significant achievement for innovative medical aesthetics, Cytrellis Biosystems, Inc. has announced that its cutting-edge ellacor® System has clinched the highly coveted NewBeauty Award for Best Nonsurgical Skin Removal Procedure in 2026. This recognition highlights the system's role in bridging the gap between skin health and restoration, offering patients a revolutionary option for rejuvenation without the need for invasive surgical procedures.

The Innovative ellacor® System

The ellacor® System leverages Micro-Coring® Technology, which utilizes precisely engineered hollow needles to extract micro-cores of excess skin. This method not only eliminates the target skin tissue but also triggers the body’s inherent healing process, leading to increased collagen and elastin production. As a result, patients benefit from reduced skin laxity and visible improvement in wrinkles, all while achieving natural-looking skin rejuvenation without any visible scars.

Denise Dajles, CEO of Cytrellis, expressed pride in the achievement, stating, “We are honored that ellacor has been recognized by NewBeauty as the Best Nonsurgical Skin Removal Procedure for Younger-Looking Skin. This award confirms our mission to redefine aesthetics by focusing on both skin quantity and quality.” Cytrellis aims to empower both patients and physicians with a novel approach to skin laxity and aging that prioritizes regenerative outcomes.

A Recognized Benchmark in Beauty

The NewBeauty Awards are esteemed within the beauty industry, as they serve as a benchmark for effective and innovative treatments. The selection process for the award is rigorous, involving in-office testing, expert evaluations, and real-world outcome assessments. ellacor's recognition underscores its ability to provide significant results for those seeking youthful skin without the downtime or risks often associated with traditional surgery.

As the market demand for nonsurgical aesthetic treatments rises, ellacor's acceptance is broadening among various aesthetic providers, including leading dermatologists and plastic surgeons. The procedure caters particularly well to individuals dealing with mild to moderate skin laxity who may not be ready or willing to undergo surgical intervention but desire tangible, lasting results.

Commitment to Expanding Access

Cytrellis is dedicated to further enhancing access to ellacor® through continued physician training, comprehensive clinical research, and robust patient education initiatives. The company is also focused on expanding its pipeline of innovations based on Micro-Coring® technology, aiming to transform the aesthetics landscape further.

For those interested in learning more about ellacor and its transformative impact on skin health, visit ellacor.com or cytrellis.com.

About Cytrellis Biosystems

Cytrellis Biosystems is at the forefront of advancing medical aesthetics using evidence-based solutions designed to surpass patient expectations. The company manufactures the ellacor® System with Micro-Coring® technology, which is the only FDA-cleared non-surgical method for addressing both moderate and severe wrinkles. Indicated for adult patients aged 22 and older, ellacor® represents a significant advancement in dermatological care as it also targets fractional skin resurfacing.

Follow Cytrellis on LinkedIn, Instagram, and Facebook to keep up with their latest developments in the field.